© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 08, 2008
We conducted a post hoc analysis of the DIGAMI 2 (Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2) trial to assess the impact of glucose-lowering treatment in 1181 diabetic patients who were discharged from the hospital after experiencing a myocardial infarction (MI).